| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |